CC BY-NC-ND 4.0 · Rev Bras Ginecol Obstet 2017; 39(10): 523-528
DOI: 10.1055/s-0037-1604259
Original Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Induction of Labor using Misoprostol in a Tertiary Hospital in the Southeast of Brazil

Indução de parto utilizando misoprostol em um hospital terciário no sudeste do Brasil
Tácito Augusto Godoy Silva
1   Mário Palmério Hospital Universitário, Universidade de Uberaba (UNIUBE), Uberaba, MG, Brazil
,
Luciano Eliziário Borges Júnior
1   Mário Palmério Hospital Universitário, Universidade de Uberaba (UNIUBE), Uberaba, MG, Brazil
,
Luisa Almeida Tahan
1   Mário Palmério Hospital Universitário, Universidade de Uberaba (UNIUBE), Uberaba, MG, Brazil
,
Taynná Ferreira Arantes Costa
1   Mário Palmério Hospital Universitário, Universidade de Uberaba (UNIUBE), Uberaba, MG, Brazil
,
Fernanda Oliveira Magalhães
1   Mário Palmério Hospital Universitário, Universidade de Uberaba (UNIUBE), Uberaba, MG, Brazil
,
Alberto Borges Peixoto
1   Mário Palmério Hospital Universitário, Universidade de Uberaba (UNIUBE), Uberaba, MG, Brazil
,
Wellington de Paula Martins
2   Department of Obstetrics and Gynecology, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil
,
Edward Araujo Júnior
3   Department of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-UNIFESP), São Paulo, SP, Brasil
› Author Affiliations
Further Information

Publication History

03 March 2017

30 May 2017

Publication Date:
12 July 2017 (online)

Abstract

Purpose To assess cases of labor induction with vaginal 25-µg tablets of misoprostol and maternal outcomes in a tertiary hospital in southeastern Brazil.

Methods This was a retrospective cohort study of 412 pregnant women with indication for labor induction. Labor induction was performed with vaginal 25-µg tablets of misoprostol in pregnant women with Bishop scores < 6. Stepwise regression analysis was used to identify the factors present at the beginning of induction that could be used as predictors of successful labor induction.

Results A total of 69% of the pregnant women who underwent labor induction progressed to vaginal delivery, and 31% of the women progressed to cesarean section. One or two misoprostol tablets were used in 244 patients (59.2%). Of the 412 patients, 197 (47.8%) required oxytocin later on in the labor process, after induction with misoprostol. The stepwise regression analysis showed that only Bishop scores of 4 and 5 and previous vaginal delivery were independent factors with statistical significance in the prediction of successful vaginal labor induction (β = 0.23, p < 0.001, for a Bishop score of 4 and 5, and β = 0.22, p < 0.001, for previous vaginal delivery).

Conclusion Higher Bishop scores and previous vaginal delivery were the best predictors of successful labor induction with vaginal 25-µg tablets of misoprostol.

Resumo

Objetivo Avaliar os casos de indução do trabalho de parto com misoprostol 25 mcg por via vaginal e seus desfechos maternos em um hospital terciário do Sudeste do Brasil.

Métodos Realizou-se um estudo retrospectivo de coorte com 412 gestantes com indicações para indução de trabalho de parto. A indução do trabalho de parto foi realizada com misoprostol 25 mcg vaginal em gestantes com índice de Bishop < 6. Realizou-se análise de regressão stepwise para identificar os fatores presentes ao início da indução que poderiam ser usados como prognosticadores do sucesso da indução do trabalho de parto.

Resultados A indução de trabalho de parto determinou 69% de partos normais, sendo que 31% evoluíram para cesárea. Em relação ao número de comprimidos de misoprostol, 1 ou 2 comprimidos foram utilizados em 244 pacientes (59,2%). Das 412 pacientes, 197 (47,8%) necessitaram de ocitocina após a indução com misoprostol para dar continuidade ao trabalho de parto. Na análise de regressão stepwise, apenas a presença de índice de Bishop 4 e 5 e parto vaginal prévio foram fatores independentes com significância estatística na predição do sucesso da indução em obter parto vaginal (β = 0,23, p < 0,001, para índice de Bishop 4 e 5, e β = 0,22, p < 0,001, para parto vaginal prévio).

Conclusão Maiores índices de Bishop e parto vaginal prévio são os maiores prognosticadores do sucesso de indução de trabalho de parto com misoprostol 25 mcg vaginal.

 
  • References

  • 1 Moraes Filho OB, Cecatti JG, Feitosa FEL. [Methods for labor induction.]. Rev Bras Ginecol Obstet 2005; 27 (08) 493-500 Portuguese.
  • 2 Sanchez-Ramos L. Induction of labor. Obstet Gynecol Clin North Am 2005; 32 (02) 181-200 , viii
  • 3 ACOG Committee on Practice Bulletins -- Obstetrics. ACOG Practice Bulletin No. 107: induction of labor. Obstet Gynecol 2009; 114 (2 Pt 1): 386-397
  • 4 Mackenzie IZ. Induction of labour at the start of the new millennium. Reproduction 2006; 131 (06) 989-998
  • 5 Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002; 17 (02) 332-336
  • 6 Stephenson ML, Wing DA. Misoprostol for induction of labor. Semin Perinatol 2015; 39 (06) 459-462
  • 7 Boulvain M, Kelly A, Irion O. Intracervical prostaglandins for induction of labour. Cochrane Database Syst Rev 2008; (01) CD006971
  • 8 Souza ASR, Scavuzzi A, Rodrigues DC, Oliveira RD, Feitosa FE, Amorim MM. [Titrated oral solution of misoprostol for labour induction: a pilot study]. Rev Bras Ginecol Obstet 2010; 32 (05) 208-213 Portuguese.
  • 9 Kavanagh J, Kelly AJ, Thomas J. Hyaluronidase for cervical ripening and induction of labour. Cochrane Database Syst Rev 2006; (02) CD003097
  • 10 Rezaie M, Farhadifar F, Sadegh SM, Nayebi M. Comparison of vaginal and oral doses of misoprostol for labour induction in post-term pregnancies. J Clin Diagn Res 2016; 10 (03) QC08-QC11
  • 11 Duro Gómez J, Garrido Oyarzún MF, Rodríguez Marín AB, de la Torre González AJ, Arjona Berral JE, Castelo-Branco C. Vaginal misoprostol and cervical ripening balloon for induction of labor in late-term pregnancies. J Obstet Gynaecol Res 2017; 43 (01) 87-91
  • 12 Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2001; (03) CD000941
  • 13 Blanchard K, Clark S, Winikoff B, Gaines G, Kabani G, Shannon C. Misoprostol for women's health: a review. Obstet Gynecol 2002; 99 (02) 316-332
  • 14 Oliveira TA, Melo EM, Aquino MM, Mariani Neto C. [Efficacy of dinoprostone and misoprostol for labor induction in nulliparous women]. Rev Bras Ginecol Obstet 2011; 33 (03) 118-122 Portuguese.
  • 15 Naeye RL. Maternal age, obstetric complications, and the outcome of pregnancy. Obstet Gynecol 1983; 61 (02) 210-216
  • 16 Main DM, Main EK, Moore II DH. The relationship between maternal age and uterine dysfunction: a continuous effect throughout reproductive life. Am J Obstet Gynecol 2000; 182 (06) 1312-1320
  • 17 Arrowsmith S, Robinson H, Noble K, Wray S. What do we know about what happens to myometrial function as women age?. J Muscle Res Cell Motil 2012; 33 (3-4): 209-217
  • 18 Dunn L, Kumar S, Beckmann M. Maternal age is a risk factor for caesarean section following induction of labour. Aust N Z J Obstet Gynaecol 2017 ; [ Epub ahead of print ]
  • 19 Tsikouras P, Koukouli Z, Manav B. , et al. Induction of labor in post-term nulliparous and parous women - potential advantages of misoprostol over dinoprostone. Geburtshilfe Frauenheilkd 2016; 76 (07) 785-792
  • 20 Blickstein I. Induction of labour. J Matern Fetal Neonatal Med 2009; 22 (Suppl. 02) 31-37
  • 21 Wing DA [Internet]. Induction of labor with oxytocin. 2017 [cited 2017 May 21]. Available from: < https://www.uptodate.com/contents/induction-of-labor-with-oxytocin >
  • 22 Brusati V, Brembilla G, Cirillo F. , et al. Efficacy of sublingual misoprostol for induction of labor at term and post term according to parity and membrane integrity: a prospective observational study. J Matern Fetal Neonatal Med 2017; 30 (05) 508-513
  • 23 Stock SJ, Ferguson E, Duffy A, Ford I, Chalmers J, Norman JE. Outcomes of elective induction of labour compared with expectant management: population based study. BMJ 2012; 344: e2838
  • 24 Darney BG, Snowden JM, Cheng YW. , et al. Elective induction of labor at term compared with expectant management: maternal and neonatal outcomes. Obstet Gynecol 2013; 122 (04) 761-769
  • 25 Boulvain M, Senat MV, Perrotin F. , et al; Groupe de Recherche en Obstétrique et Gynécologie (GROG). Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet 2015; 385 (9987): 2600-2605
  • 26 Friedman EA, Niswander KR, Bayonet-Rivera NP, Sachtleben MR. Relation of prelabor evaluation to inducibility and the course of labor. Obstet Gynecol 1966; 28 (04) 495-501
  • 27 Hughey MJ, McElin TW, Bird CC. An evaluation of preinduction scoring systems. Obstet Gynecol 1976; 48 (06) 635-641
  • 28 Dhall K, Mittal SC, Kumar A. Evaluation of preinduction scoring systems. Aust N Z J Obstet Gynaecol 1987; 27 (04) 309-311
  • 29 Ezebialu IU, Eke AC, Eleje GU, Nwachukwu CE. Methods for assessing pre-induction cervical ripening. Cochrane Database Syst Rev 2015; (06) CD010762
  • 30 Pajak J, Tomiałowicz M, Florjański J. , et al. [Comparison of vaginal misoprostol and oxytocin for labor induction in post-term pregnancy]. Ginekol Pol 2001; 72 (12A): 1300-1304 Polish.
  • 31 Sharami SH, Milani F, Faraji R. , et al. Comparison of 25 µg sublingual and 50 µg intravaginal misoprostol for cervical ripening and labor: a randomized controlled equivalence trial. Arch Iran Med 2014; 17 (10) 652-656
  • 32 Santo S, Lourenço R, Centeno M. , et al. Labor induction with 25-microg misoprostol vaginal capsules. Gynecol Obstet Invest 2009; 68 (04) 272-275